Fuse Medical, Inc.

Equities

FZMD

US36113U1016

Medical Equipment, Supplies & Distribution

Delayed OTC Markets 10:54:05 2024-04-18 am EDT 5-day change 1st Jan Change
0.0988 USD +3.95% Intraday chart for Fuse Medical, Inc. 0.00% -14.09%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Earnings Flash (FZMD) FUSE MEDIAL Reports Q2 Revenue $5M MT
Fuse Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Fuse Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Fuse Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Fuse Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Fuse Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Fuse Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Fuse Medical, Inc. Appoints Lawrence S. Yellin as Treasurer and Member of the Board CI
Fuse Medical, Inc. Announces Executive Changes CI
Fuse Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Fuse Medical, Inc. Announces Exclusive US Distribution Agreement with BRM Extremities for Silktoe Arthroplasty Implant CI
Fuse Medical, Inc. Announces Resignation of William E. McLaughlin, III as Chief Financial Officer CI
Fuse Medical, Inc., CPM Medical Consultants, LLC and Zions Bancorporation, N.A. Execute Eighth Amendment to the Amended and Restated Business Loan Agreement CI
Earnings Flash (FZMD) FUSE MEDICAL Posts Q3 Revenue $4.3M MT
Fuse Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Fuse Medical, Inc. Announces Official Launch of FuseChoice™ Dermal Matrix CI
Fuse Medical, Inc. Announces FDA 510(K) Clearance of the Sterizo™ Tibial Revision Knee System and PS Plus Posterior Stabilized Tibial Insert CI
Fuse Medical, Inc. Announces Initial Launch of Orbitum Compression Staple System CI
Fuse Medical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Fuse Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Fuse Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Fuse Medical, Inc. Announces an Agreement with Orthovestments, LLC for Exclusive Manufacturing and Commercialization of the Orbitum™ Staple System CI
Fuse Medical, Inc. Enters into Marketing Agreement with Carepics Telehealth CI
Fuse Medical, Inc. Enters Into Marketing Agreement With CarePICS Telehealth CI
Fuse Medical, Inc. Announces Launch of FuseChoice Biologics Portfolio CI
Chart Fuse Medical, Inc.
More charts
Fuse Medical, Inc. is a manufacturer and distributor of medical devices in the United States. The Company provides a range of a portfolio of orthopedic implants, including foot and ankle, orthopedics, sports medicine and spine. It also provides a range of osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. Its foot and ankle product offerings include internal and external fixation for forefoot, midfoot and hindfoot reconstruction. Its orthopedics offer joint reconstruction systems for upper and lower extremities, which include the sterizo total knee, tibial revision, and total hip replacement systems, as well as the arrow total and reverse total shoulder system. Its sports medicine offers a line of fuse suture anchors and interference screws, as well as multiple products for soft tissue fixation augmentation. Its spine offers spinal products for cervical and thoracolumbar fusion.
More about the company
  1. Stock Market
  2. Equities
  3. FZMD Stock
  4. News Fuse Medical, Inc.
  5. Earnings Flash (FZMD) FUSE MEDIAL Reports Q2 Revenue $5M